Actively Recruiting
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
Led by Ruijin Hospital · Updated on 2024-12-13
40
Participants Needed
1
Research Sites
145 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to investigate the value of 68Ga-grazytracer in predicting the efficacy of immunotherapy for advanced soft tissue sarcomas.
CONDITIONS
Official Title
The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Advanced Soft Tissue Sarcomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pathological and clinical diagnosis of advanced soft tissue sarcomas, including fibrosarcoma, liposarcoma, undifferentiated pleomorphic sarcoma, epithelioid sarcoma, rhabdomyosarcoma, synovial sarcoma, alveolar soft-part sarcoma, leiomyosarcoma, clear cell sarcoma, malignant schwannoma, angiosarcoma
- Planned immunotherapy or combined immunotherapy based on clinical judgement
- Signed and dated informed consent form
- Commitment to comply with research procedures and cooperate fully
- Aged between 6 and 80 years old
You will not qualify if you...
- Serious illnesses such as severe heart or lung failure, severe bone marrow suppression, severe liver or kidney dysfunction
- Intestinal perforation or complete intestinal obstruction
- Pregnant women, women who may be pregnant, or breastfeeding women
- Persons who are non-compliant with study procedures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Shanghai, Shanghai Municipality, China, 200001
Actively Recruiting
Research Team
J
Jiajia Hu
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here